Review





Similar Products

human m csf  (MedChemExpress)
94
MedChemExpress human m csf
Human M Csf, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human m csf/product/MedChemExpress
Average 94 stars, based on 1 article reviews
human m csf - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier
m csf  (Miltenyi Biotec)
96
Miltenyi Biotec m csf
M Csf, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m csf/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
m csf - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
mouse m csf  (MedChemExpress)
96
MedChemExpress mouse m csf
Mouse M Csf, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse m csf/product/MedChemExpress
Average 96 stars, based on 1 article reviews
mouse m csf - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
human gm csf  (Miltenyi Biotec)
96
Miltenyi Biotec human gm csf
Human Gm Csf, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human gm csf/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
human gm csf - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
female gm csf knockout mice  (Jackson Laboratory)
86
Jackson Laboratory female gm csf knockout mice
<t>GM-CSF</t> <t>transgene</t> and aPAP mouse phenotype lung-level quantification at 2.5 weeks (100 μL and 10 × 5 μL treated mice given 2.3e8TU vector) and 2 months (5 × 5 μL treated mice given 6e7TU vector) post intranasal rSIV.F/HN treatment (A) Bronchoalveolar lavage fluid (BALF) GM-CSF levels measured by ELISA (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median; dotted line = lowest experimental standard of 7.8 pg/mL). (B) BALF turbidity measured as optical density (OD: 600 nM) (ANOVA, n = 6–15, p < 0.0005: Tukey’s post-hoc test) (data are represented as individual values with median). (C) Pulmonary alveolar surfactant (PAS) staining example images from no-dose and 100 μL bolus-treated mouse lungs (left) and image analysis quantification of all left-lung lobes (right) (Welch’s ANOVA, n = 6–15, p < 0.005: Dunnett’s post-hoc test) (data are represented as individual values with mean ± SD). (D) Example images showing how lung consolidation was measured from PAS-stained whole left-lung coronal sections (left), using image analysis to measure whole-lung area (middle) and consolidation area (right). (E) Consolidation area, as a percentage of total tissue area, plotted across all left-lung samples (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median). ∗ = p < 0.05; ∗∗ = p < 0.005; ∗∗∗ = p < 0.0005; ∗∗∗∗ = p < 0.0001.
Female Gm Csf Knockout Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/female gm csf knockout mice/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews
female gm csf knockout mice - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
il3  (R&D Systems)
96
R&D Systems il3
<t>GM-CSF</t> <t>transgene</t> and aPAP mouse phenotype lung-level quantification at 2.5 weeks (100 μL and 10 × 5 μL treated mice given 2.3e8TU vector) and 2 months (5 × 5 μL treated mice given 6e7TU vector) post intranasal rSIV.F/HN treatment (A) Bronchoalveolar lavage fluid (BALF) GM-CSF levels measured by ELISA (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median; dotted line = lowest experimental standard of 7.8 pg/mL). (B) BALF turbidity measured as optical density (OD: 600 nM) (ANOVA, n = 6–15, p < 0.0005: Tukey’s post-hoc test) (data are represented as individual values with median). (C) Pulmonary alveolar surfactant (PAS) staining example images from no-dose and 100 μL bolus-treated mouse lungs (left) and image analysis quantification of all left-lung lobes (right) (Welch’s ANOVA, n = 6–15, p < 0.005: Dunnett’s post-hoc test) (data are represented as individual values with mean ± SD). (D) Example images showing how lung consolidation was measured from PAS-stained whole left-lung coronal sections (left), using image analysis to measure whole-lung area (middle) and consolidation area (right). (E) Consolidation area, as a percentage of total tissue area, plotted across all left-lung samples (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median). ∗ = p < 0.05; ∗∗ = p < 0.005; ∗∗∗ = p < 0.0005; ∗∗∗∗ = p < 0.0001.
Il3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il3/product/R&D Systems
Average 96 stars, based on 1 article reviews
il3 - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
wt reovirus sargramostim gm csf  (Schuelke)
86
Schuelke wt reovirus sargramostim gm csf
<t>GM-CSF</t> <t>transgene</t> and aPAP mouse phenotype lung-level quantification at 2.5 weeks (100 μL and 10 × 5 μL treated mice given 2.3e8TU vector) and 2 months (5 × 5 μL treated mice given 6e7TU vector) post intranasal rSIV.F/HN treatment (A) Bronchoalveolar lavage fluid (BALF) GM-CSF levels measured by ELISA (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median; dotted line = lowest experimental standard of 7.8 pg/mL). (B) BALF turbidity measured as optical density (OD: 600 nM) (ANOVA, n = 6–15, p < 0.0005: Tukey’s post-hoc test) (data are represented as individual values with median). (C) Pulmonary alveolar surfactant (PAS) staining example images from no-dose and 100 μL bolus-treated mouse lungs (left) and image analysis quantification of all left-lung lobes (right) (Welch’s ANOVA, n = 6–15, p < 0.005: Dunnett’s post-hoc test) (data are represented as individual values with mean ± SD). (D) Example images showing how lung consolidation was measured from PAS-stained whole left-lung coronal sections (left), using image analysis to measure whole-lung area (middle) and consolidation area (right). (E) Consolidation area, as a percentage of total tissue area, plotted across all left-lung samples (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median). ∗ = p < 0.05; ∗∗ = p < 0.005; ∗∗∗ = p < 0.0005; ∗∗∗∗ = p < 0.0001.
Wt Reovirus Sargramostim Gm Csf, supplied by Schuelke, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wt reovirus sargramostim gm csf/product/Schuelke
Average 86 stars, based on 1 article reviews
wt reovirus sargramostim gm csf - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
mcsf  (R&D Systems)
96
R&D Systems mcsf
<t>GM-CSF</t> <t>transgene</t> and aPAP mouse phenotype lung-level quantification at 2.5 weeks (100 μL and 10 × 5 μL treated mice given 2.3e8TU vector) and 2 months (5 × 5 μL treated mice given 6e7TU vector) post intranasal rSIV.F/HN treatment (A) Bronchoalveolar lavage fluid (BALF) GM-CSF levels measured by ELISA (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median; dotted line = lowest experimental standard of 7.8 pg/mL). (B) BALF turbidity measured as optical density (OD: 600 nM) (ANOVA, n = 6–15, p < 0.0005: Tukey’s post-hoc test) (data are represented as individual values with median). (C) Pulmonary alveolar surfactant (PAS) staining example images from no-dose and 100 μL bolus-treated mouse lungs (left) and image analysis quantification of all left-lung lobes (right) (Welch’s ANOVA, n = 6–15, p < 0.005: Dunnett’s post-hoc test) (data are represented as individual values with mean ± SD). (D) Example images showing how lung consolidation was measured from PAS-stained whole left-lung coronal sections (left), using image analysis to measure whole-lung area (middle) and consolidation area (right). (E) Consolidation area, as a percentage of total tissue area, plotted across all left-lung samples (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median). ∗ = p < 0.05; ∗∗ = p < 0.005; ∗∗∗ = p < 0.0005; ∗∗∗∗ = p < 0.0001.
Mcsf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mcsf/product/R&D Systems
Average 96 stars, based on 1 article reviews
mcsf - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
recombinant human macrophage colony  (R&D Systems)
96
R&D Systems recombinant human macrophage colony
<t>GM-CSF</t> <t>transgene</t> and aPAP mouse phenotype lung-level quantification at 2.5 weeks (100 μL and 10 × 5 μL treated mice given 2.3e8TU vector) and 2 months (5 × 5 μL treated mice given 6e7TU vector) post intranasal rSIV.F/HN treatment (A) Bronchoalveolar lavage fluid (BALF) GM-CSF levels measured by ELISA (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median; dotted line = lowest experimental standard of 7.8 pg/mL). (B) BALF turbidity measured as optical density (OD: 600 nM) (ANOVA, n = 6–15, p < 0.0005: Tukey’s post-hoc test) (data are represented as individual values with median). (C) Pulmonary alveolar surfactant (PAS) staining example images from no-dose and 100 μL bolus-treated mouse lungs (left) and image analysis quantification of all left-lung lobes (right) (Welch’s ANOVA, n = 6–15, p < 0.005: Dunnett’s post-hoc test) (data are represented as individual values with mean ± SD). (D) Example images showing how lung consolidation was measured from PAS-stained whole left-lung coronal sections (left), using image analysis to measure whole-lung area (middle) and consolidation area (right). (E) Consolidation area, as a percentage of total tissue area, plotted across all left-lung samples (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median). ∗ = p < 0.05; ∗∗ = p < 0.005; ∗∗∗ = p < 0.0005; ∗∗∗∗ = p < 0.0001.
Recombinant Human Macrophage Colony, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human macrophage colony/product/R&D Systems
Average 96 stars, based on 1 article reviews
recombinant human macrophage colony - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

Image Search Results


GM-CSF transgene and aPAP mouse phenotype lung-level quantification at 2.5 weeks (100 μL and 10 × 5 μL treated mice given 2.3e8TU vector) and 2 months (5 × 5 μL treated mice given 6e7TU vector) post intranasal rSIV.F/HN treatment (A) Bronchoalveolar lavage fluid (BALF) GM-CSF levels measured by ELISA (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median; dotted line = lowest experimental standard of 7.8 pg/mL). (B) BALF turbidity measured as optical density (OD: 600 nM) (ANOVA, n = 6–15, p < 0.0005: Tukey’s post-hoc test) (data are represented as individual values with median). (C) Pulmonary alveolar surfactant (PAS) staining example images from no-dose and 100 μL bolus-treated mouse lungs (left) and image analysis quantification of all left-lung lobes (right) (Welch’s ANOVA, n = 6–15, p < 0.005: Dunnett’s post-hoc test) (data are represented as individual values with mean ± SD). (D) Example images showing how lung consolidation was measured from PAS-stained whole left-lung coronal sections (left), using image analysis to measure whole-lung area (middle) and consolidation area (right). (E) Consolidation area, as a percentage of total tissue area, plotted across all left-lung samples (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median). ∗ = p < 0.05; ∗∗ = p < 0.005; ∗∗∗ = p < 0.0005; ∗∗∗∗ = p < 0.0001.

Journal: Molecular Therapy Advances

Article Title: Using the nose as a factory to secrete proteins into the lungs or circulation

doi: 10.1016/j.omta.2026.201733

Figure Lengend Snippet: GM-CSF transgene and aPAP mouse phenotype lung-level quantification at 2.5 weeks (100 μL and 10 × 5 μL treated mice given 2.3e8TU vector) and 2 months (5 × 5 μL treated mice given 6e7TU vector) post intranasal rSIV.F/HN treatment (A) Bronchoalveolar lavage fluid (BALF) GM-CSF levels measured by ELISA (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median; dotted line = lowest experimental standard of 7.8 pg/mL). (B) BALF turbidity measured as optical density (OD: 600 nM) (ANOVA, n = 6–15, p < 0.0005: Tukey’s post-hoc test) (data are represented as individual values with median). (C) Pulmonary alveolar surfactant (PAS) staining example images from no-dose and 100 μL bolus-treated mouse lungs (left) and image analysis quantification of all left-lung lobes (right) (Welch’s ANOVA, n = 6–15, p < 0.005: Dunnett’s post-hoc test) (data are represented as individual values with mean ± SD). (D) Example images showing how lung consolidation was measured from PAS-stained whole left-lung coronal sections (left), using image analysis to measure whole-lung area (middle) and consolidation area (right). (E) Consolidation area, as a percentage of total tissue area, plotted across all left-lung samples (Kruskal-Wallis, n = 6–15, p < 0.0001: Dunn’s post-hoc test) (data are represented as individual values with median). ∗ = p < 0.05; ∗∗ = p < 0.005; ∗∗∗ = p < 0.0005; ∗∗∗∗ = p < 0.0001.

Article Snippet: In this study arm, male and female GM-CSF knockout mice (B6.129S-Csf2 tm1Mlg /J, Jackson Laboratory, Bar Harbor, Maine, USA) of approximately 6 months of age were intranasally administered viral vector diluted in TSSM to achieve target total doses.

Techniques: Plasmid Preparation, Enzyme-linked Immunosorbent Assay, Staining